Titan Medical Inc. completes C$25.6M public offering

Date Closed: 4/23/2014

Value: C$25.6 million

Titan Medical Inc. completed a public offering of 12,203,189 units. The Units were issued by Titan at a price of $2.10 per Unit for aggregate gross proceeds of $25,626,697 pursuant to an agency agreement dated April 10, 2014 with Dundee Securities Ltd., acting as agent. The Units were qualified for sale by a prospectus supplement dated April 10, 2014 to Titan’s short form base shelf prospectus dated October 15, 2012. Each Unit consists of one common share of Titan and one common share purchase warrant. Each whole Warrant entitles the holder thereof to acquire one Common Share at a price of $2.75 prior to the expiry time of 5:00 p.m. (Toronto time) on April 23, 2017. 

The net proceeds of the offering will be used by Titan for ongoing development and commercialization of robotic surgery technologies and general working capital requirements.

Titan was represented by BLG with a team consisting of Manoj Pundit, Habeeb Syed, Mark Lau and Natasha Miklaucic.